Company: ANY
Filing Date: 2025-04-17
Form Type: DEF 14A
Source: 0001628280-25-018222
Chunk: 62

Company: Sphere 3D Corp.
Filing Date: 2025-04-17
Form: DEF 14A
Chunk 62
---
 -4 |     | 3.4%                    |
| Kurt L. Kalbfleisch                                                 |     |                    267,976 |     | -5 |     | 1.0%                    |
| Timothy Hanley                                                      |     |                    217,279 |     | -6 |     | *                       |
| Susan S. Harnett                                                    |     |                    199,707 |     | -7 |     | *                       |
| Duncan McEwan                                                       |     |                    290,399 |     | -8 |     | 1.1%                    |
| All current directors and executive officers as a group (4 persons) |     |                    975,361 |     |    |     | 3.6%                    |

____________________

* Less than 1%

(1) These amounts include common shares, which could be acquired upon exercise or vesting of outstanding convertible securities within 60 days.

(2) Based on 26,178,282 common shares outstanding as of April 7, 2025.

(3) Based on the Schedule 13G filed by Armistice Capital, LLC (“ Armistice Capital ”) and Steven Boyd with the SEC on February 14, 2025, Armistice Capital beneficially owned 2,583,718 common shares, with shared voting and dispositive power. The investment manager of Armistice Capital Master Fund Ltd. (the “ Master Fund ”), the direct holder of the common shares, and pursuant to an Investment Management Agreement, Armistice Capital exercises voting and investment power over the securities of the Company held by the Master Fund and thus may be deemed to beneficially own the securities of the Company held by the Master Fund. Mr. Boyd, as the managing member of Armistice Capital, may be deemed to beneficially own the securities of the Company held by the Master Fund. The Master Fund specifically disclaims beneficial ownership of the securities of the Company directly held by it by virtue of its inability to vote or dispose of such securities as a result of its Investment Management Agreement with Armistice Capital. According to the Company’s records, Armistice Capital holds (i) 4,368,211 common share warrants for the purchase of 4,368,211 common shares with an exercise price of $1.50 with an initial exercise date of May 21, 2025, and (ii) common share warrants for the purchase of 1,087,000 pref